AGEPHA
LIVE

Serial Number

88325857

Owner

Murray & Poole Enterprises Ltd

Attorney

Jeffrey H. Handelsman

First Use Date

Jan 1, 2019

Filing Date

Mar 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AGEPHA Trademark

Serial Number: 88325857 • Registration: 6070487

AGEPHA is a trademark filed by Murray & Poole Enterprises Ltd on March 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Murray & Poole Enterprises Ltd (13 trademarks)

c/o N.J. Akers & Co. Limited,

Entity Type: 99

AGEPHA Pharma s.r.o. (2 trademarks)

Dial¿nicná cesta 5

Entity Type: 16

Trademark Details

Filing Date

March 5, 2019

Registration Date

June 2, 2020

First Use Anywhere

January 1, 2019

First Use in Commerce

January 1, 2019

Published for Opposition

January 14, 2020

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceuticals, namely, anti-infectives; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical agents for epidermis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, ophthalmological preparations; Pharmaceutical preparations, namely, preparations for prophylaxes and/or treatment of the cardiovascular system; Dietetic substances adapted for medical use

Filing History

TEAS SECTION 8 & 15 RECEIVED
Dec 19, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 2, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 8, 2023 ASGN
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 30, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 29, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 24, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 24, 2020 AITU
USE AMENDMENT FILED
Apr 9, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 9, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 10, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2019 NONP
ASSIGNED TO LIE
Dec 9, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 21, 2019 CNRT
ASSIGNED TO EXAMINER
May 14, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2019 NWOS
NEW APPLICATION ENTERED
Mar 8, 2019 NWAP